Search

everythinglearnresearchcommunity

for

Search:↓

Oral contraceptives lower testosterone levels in women, especially those with certain genetic traits, and may be linked to increased breast cancer risk.

Male rats have androgen receptors in their liver, which are different from proteins that bind estrogen.

Men with hair loss have more DNA changes in back-of-head hair follicles, possibly protecting them from thinning.

African American men with prostate cancer have more androgen receptor mutations, which may lead to more aggressive cancer compared to Caucasian American men.

AR gene not major factor in female hair loss; different from male hair loss.

PF-998425 is a new, effective, and non-phototoxic treatment for skin conditions related to androgens.

Spironolactone reduces the number of androgen receptor sites in rat skin by blocking them with its metabolite.

Finasteride works better for baldness in people with shorter gene repeats.

Finasteride may improve prostate cancer treatment outcomes.

Certain changes to the B-ring of androgen receptor ligands can increase their effectiveness for potential treatments of muscle and bone conditions.

The protein ARA70/ELE1 is involved in male pattern baldness, and lower levels of its short form may lead to hair thinning.

The study concludes that a genetic mutation in TFM mice leads to reduced androgen receptor activity, affecting the body's response to male hormones.

TGF-β1 increases androgen receptor activity in hair loss, but Hic-5/ARA55 can counter this effect.

The nature of the side chain in RU 58841 derivatives greatly affects its AR affinity, with the N-(iodopropenyl) derivative 13 showing the highest AR binding affinity, suggesting its potential for developing high-affinity radioiodinated AR radioligands.

New treatments for prostate cancer are less toxic and show promise, but more research is needed to enhance their effectiveness and reduce side effects.

A compound made by Pfizer can potentially stimulate hair growth and reduce oil production, making it a good candidate for topical use.

Longer CAG and GGN repeats increase alopecia risk, but no significant link to post-finasteride syndrome found.

Women with greater androgen sensitivity respond better to finasteride for hair loss.

Androgens and SARMs play a role in body mass, frailty, skin health, and hair growth, and are used in treating prostate cancer, acne, and hair loss, with potential for new uses and improved versions in the future.

Scientists restored fertility in male mice lacking a key fertility gene by using a modified gene.

Metformin works better for adolescent girls with PCOS who have certain genetic variations.

Finasteride side effects in young men may be linked to specific gene variations.

The compound (1R,2S)-4-(2-Cyano-cyclohexyl-oxy)-2-trifluoromethyl-benzonitrile can stimulate hair growth and reduce oil production when applied topically.

Adding cerium(III) chloride to Grignard reagents improves the making of compounds that could treat prostate issues and hair loss.

No clear link between androgen receptor variation and hair loss, but more research needed.

Pumpkin seed products may help improve prostate and bladder health by blocking certain enzymes and hormone receptors.

Dutasteride and finasteride affect different cell types differently.

Changes in testosterone and estrogen receptor genes can affect how men age, influencing body fat, hair patterns, and possibly leading to skin disorders.

DHT affects bone growth by altering gene activity in osteoblasts, potentially complicating steroid use.

We need better ways to test and understand SARMs to make safer and more effective treatments.